-
1
-
-
34248683583
-
Chemoprevention of breast cancer for women at high risk
-
Chan K, Morris GJ. Chemoprevention of breast cancer for women at high risk. Semin Oncol 2006; 33: 642-646
-
(2006)
Semin Oncol
, vol.33
, pp. 642-646
-
-
Chan, K.1
Morris, G.J.2
-
2
-
-
0038063512
-
Breast cancer chemoprevention: Risk-benefit effects of the antioestrogen tamoxifen
-
Brown K. Breast cancer chemoprevention: risk-benefit effects of the antioestrogen tamoxifen. Expert Opin Drug Saf 2002; 1: 253-267
-
(2002)
Expert Opin Drug Saf
, vol.1
, pp. 253-267
-
-
Brown, K.1
-
3
-
-
0036468899
-
Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer
-
Ristimäki A, Sivula A, Lundin J, et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 2002; 62: 632-635
-
(2002)
Cancer Res
, vol.62
, pp. 632-635
-
-
Ristimäki, A.1
Sivula, A.2
Lundin, J.3
-
5
-
-
26844553637
-
JTE-522, a selective COX-2 inhibitor, inhibits growth of pulmonary metastases of colorectal cancer in rats
-
Kobayashi H, Uetake H, Higuchi T, et al. JTE-522, a selective COX-2 inhibitor, inhibits growth of pulmonary metastases of colorectal cancer in rats. BMC Cancer 2005; 5: 26-33.
-
(2005)
BMC Cancer
, vol.5
, pp. 26-33
-
-
Kobayashi, H.1
Uetake, H.2
Higuchi, T.3
-
6
-
-
33748358343
-
Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression
-
Larkins TL, Nowell M, Singh S, et al. Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression. BMC Cancer 2006; 10: 181-192
-
(2006)
BMC Cancer
, vol.10
, pp. 181-192
-
-
Larkins, T.L.1
Nowell, M.2
Singh, S.3
-
7
-
-
34347401285
-
Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality
-
Bardia A, Ebbert JO, Vierkant RA, et al. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality. J Natl Cancer Inst 2007; 99: 881-889
-
(2007)
J Natl Cancer Inst
, vol.99
, pp. 881-889
-
-
Bardia, A.1
Ebbert, J.O.2
Vierkant, R.A.3
-
8
-
-
0141842615
-
Breast cancer and nonsteroidal antiinflammatory drugs: Prospective results from the Women's health initiative
-
Harris RE, Chlebowski RT, Jackson RD, et al. Breast cancer and nonsteroidal antiinflammatory drugs: prospective results from the Women's health initiative. Cancer Res 2003; 63: 6096-6101
-
(2003)
Cancer Res
, vol.63
, pp. 6096-6101
-
-
Harris, R.E.1
Chlebowski, R.T.2
Jackson, R.D.3
-
9
-
-
18344376608
-
Association of regular aspirin use and breast cancer risk
-
Swede H, Mirand AL, Menezes RJ, et al. Association of regular aspirin use and breast cancer risk. Oncology 2005; 68: 40-47
-
(2005)
Oncology
, vol.68
, pp. 40-47
-
-
Swede, H.1
Mirand, A.L.2
Menezes, R.J.3
-
10
-
-
23444434370
-
Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: The Case-Control Surveillance Study revisited
-
Zhang Y, Coogan PF, Palmer JR, et al. Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited. Am J Epidemiol 2005; 162: 165-170
-
(2005)
Am J Epidemiol
, vol.162
, pp. 165-170
-
-
Zhang, Y.1
Coogan, P.F.2
Palmer, J.R.3
-
11
-
-
0034130336
-
Aspirin induction of apoptosis in esophageal cancer: A potential for chemoprevention
-
Li M, Lotan R, Levin B, et al. Aspirin induction of apoptosis in esophageal cancer: a potential for chemoprevention. Cancer Epidemiol Biomark Prev 2000; 9: 545-549
-
(2000)
Cancer Epidemiol Biomark Prev
, vol.9
, pp. 545-549
-
-
Li, M.1
Lotan, R.2
Levin, B.3
-
12
-
-
0032188853
-
NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and downregulates bcl-2 expression in LNCaP cells
-
Liu XH, Yao S, Kirschenbaum A, et al. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and downregulates bcl-2 expression in LNCaP cells. Cancer Res 1998; 58: 4245-4249
-
(1998)
Cancer Res
, vol.58
, pp. 4245-4249
-
-
Liu, X.H.1
Yao, S.2
Kirschenbaum, A.3
-
13
-
-
0030947525
-
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2
-
Sheng H, Shao J, Kirkland SC, et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 1997; 99: 2254-2259
-
(1997)
J Clin Invest
, vol.99
, pp. 2254-2259
-
-
Sheng, H.1
Shao, J.2
Kirkland, S.C.3
-
14
-
-
0042334817
-
Microsomal prostaglandin E synthase-1 is overexpressed in head and neck squamous cell carcinoma
-
Cohen EG, Almahmeed T, Du B, et al. Microsomal prostaglandin E synthase-1 is overexpressed in head and neck squamous cell carcinoma.Clin Cancer Res 2003; 9: 3425-3430
-
(2003)
Clin Cancer Res
, vol.9
, pp. 3425-3430
-
-
Cohen, E.G.1
Almahmeed, T.2
Du, B.3
-
15
-
-
0035947586
-
Prostaglandin E2 increases growth and motility of colorectal carcinoma cells
-
Sheng H, Shao J, Washington MK, et al. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 2001; 276: 18075-18081
-
(2001)
J Biol Chem
, vol.276
, pp. 18075-18081
-
-
Sheng, H.1
Shao, J.2
Washington, M.K.3
-
16
-
-
0035902115
-
Proliferation, cell cycle and apoptosis in cancer
-
Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411: 342-348
-
(2001)
Nature
, vol.411
, pp. 342-348
-
-
Evan, G.I.1
Vousden, K.H.2
-
17
-
-
0035906809
-
Chemoprevention of intestinal tumorigenesis by nabumetone: Induction of apoptosis and Bcl-2 downregulation
-
Roy HK, Karoski WJ, Ratashak A, et al. Chemoprevention of intestinal tumorigenesis by nabumetone: induction of apoptosis and Bcl-2 downregulation. Br J Cancer 2001; 84: 1412-1416
-
(2001)
Br J Cancer
, vol.84
, pp. 1412-1416
-
-
Roy, H.K.1
Karoski, W.J.2
Ratashak, A.3
-
19
-
-
34250218734
-
Additive effects of Cox-1 and Cox-2 inhibition on breast cancer in vitro
-
McFadden DW, Riggs DR, Jackson BJ, et al. Additive effects of Cox-1 and Cox-2 inhibition on breast cancer in vitro. Int J Oncol 2006; 29: 1019-1023
-
(2006)
Int J Oncol
, vol.29
, pp. 1019-1023
-
-
McFadden, D.W.1
Riggs, D.R.2
Jackson, B.J.3
-
20
-
-
33746896137
-
Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma
-
Schulze-Bergkamen H, Friess H, Stremmel W, Krammer PH, Schirmacher P, Müller M.
-
Kern MA, Haugg AM, Koch AF, et al. Schulze-Bergkamen H, Friess H, Stremmel W, Krammer PH, Schirmacher P, Müller M. Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma. Cancer Res 2006; 66: 7059-7066
-
(2006)
Cancer Res
, vol.66
, pp. 7059-7066
-
-
Kern, M.A.1
Haugg, A.M.2
Koch, A.F.3
-
22
-
-
0032575750
-
Caspases: Enemies within
-
Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281: 1312-1316
-
(1998)
Science
, vol.281
, pp. 1312-1316
-
-
Thornberry, N.A.1
Lazebnik, Y.2
-
23
-
-
0031037897
-
The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
-
Kluck RM, Bossy-Wetzel E, Green DR, et al. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 1997; 275: 1132-1136
-
(1997)
Science
, vol.275
, pp. 1132-1136
-
-
Kluck, R.M.1
Bossy-Wetzel, E.2
Green, D.R.3
-
24
-
-
0031036872
-
Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
-
Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997; 275: 1129-1132
-
(1997)
Science
, vol.275
, pp. 1129-1132
-
-
Yang, J.1
Liu, X.2
Bhalla, K.3
-
25
-
-
0035736259
-
Organelle-specific initiation of cell death pathways
-
Ferri KF, Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol 2001; 3: E255-63.
-
(2001)
Nat Cell Biol
, vol.3
-
-
Ferri, K.F.1
Kroemer, G.2
|